New diagnostic approaches into diseases: Protein chip technology;Hastaliklara yeni bir tani yaklaşimi: Protein-çip teknolojisi

Gulhane Medical Journal

Volumn 47, Issue 3, 2005, Pages 243-245

  Güran, Şefik ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Biochip; Cancer; Microarray; Protein chip technology

Indexed keywords

DNA; PROSTATE SPECIFIC ANTIGEN; PROTEIN; RNA; TUMOR ANTIGEN; TUMOR MARKER;

BIOINFORMATICS; BIOTECHNOLOGY; CANCER; COMPUTER PROGRAM; DIAGNOSTIC APPROACH ROUTE; DNA MICROARRAY; HUMAN; HUMAN GENOME; MEDICAL TECHNOLOGY; PROGNOSIS; PROTEOMICS; REVIEW;

EID: 27744486329     PISSN: 13020471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Peltonen L, Mc Kusick VA. Genomics and medicine. Dissecting human disease in the postgenomic era. Science 2001; 291: 1224-1229.
2. Güran Ş. İnsan genom projesi: dünü bugünü ve yarini. Gülhane Tip Dergisi 2001; 43: 440-443.
3. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of Cell. 4th ed. New York: Garland Science, 2002.
4. Connor M, Ferguson-Smith M. Essential Medical Genetics. 5th ed, New York: Blackwell Science, 1997.
5. Chapman K. The protein chip biomarker system from ciphergen biosystems: a novel proteomics platform for rapid biomarker discovery and validation. Biochem Soc Trans 2002; 30: 82-87.
6. Kodadek T. Development of protein-detecting microarrrays and related devices. Trends Biochem Sci 2002; 27: 295-300.
7. Falsey JR, Renil M, Park S, Li S, Lam KS. Peptide and small molecule microarrray for high throughput cell adhesion and functional assays. Bioconjug Chem 2001; 12: 346-353.
8. Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412: 822-826.
9. Kodatek T, Reddy MM, Olivos HJ, Bachawat-Sikder K, Alluri PG. Synthetic molecules as antibody replacements. Acc Chem Res 2004; 37: 711-718.
10. Pandey A, Mann M. Proteomics to study genes and genomes. Nature 2000; 405: 837-846.
11. Washburn MP, Wolters D, Yates JR 3rd. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001; 19: 242-247.
12. Moore CA, Klioury MJ, Bradley LA. From genetics to genomics using gene-based medicine to prevent disease and promote health in children. Semin Perinatol 2005; 29: 135-143.
13. Zhang L, Yu W, He T, et al. Contribution of human alfa defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 2002; 298: 995-1000.
14. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572-577.
15. De Vita VT, Hellman S, Rosenberg SA. Cancer, Principles and Practice of Oncology. 4th ed. Philadelphia: JB Lippincott Co, 1993.
16. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomix and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002; 48: 1296-1304.
17. Borsting C, Sanches JJ, Morling N. Multiplex PCR, amplicon size and hybridization efficiency on the NanoChip electronic microarray. Int J Legal Med 2004; 118: 75-82.
18. Horsthemke B, Nazhcan H, Husing J, et al. Somatic mosaicism for maternal uniparental disomy 15 in a girl with Prader-Willi syndrome: confirmation by cell cloning and identification of candidade downstream genes. Hum Mol Genet 2003; 12: 2723-2732.
19. Bittel DC, Kibiryeva N, Talebizadeh Z, Butler MG. Microarray analysis of gene/transcript expression in Prader-Willi syndrome: deletion versus UPD. J Med Genet 2003; 40: 568-574.